Navigation Links
Spherix to Raise $1.25 Million in Private Placement
Date:10/26/2011

BETHESDA, Md., Oct. 26, 2011 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) – an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies – today announced that it has entered into definitive agreements to sell $1.25 million of shares of its common stock together with warrants to purchase additional shares of its common stock in a private placement transaction.  The closing of the offering is expected to occur on or about October 28, 2011, subject to customary closing conditions, at which time Spherix will receive the cash proceeds and deliver the securities.

Under the terms of the offering, the Company will sell an aggregate of 532,559 shares of common stock at a price of $2.365 per share along with warrants to purchase an additional 532,559 shares of common stock at an exercise price of $2.24 per share.  The warrants are exercisable immediately after closing and expire in five years.  The Company is required to file a resale registration statement within 30 days following the closing that covers the resale by the investors of the shares and the shares issuable upon exercise of the warrants. .

The Company intends to use the net proceeds from the offering to continue the development of SPX-106T (the combination of D tagatose and SPX-106), as well as for general corporate purposes.

Rodman & Renshaw, LLC, a wholly-owned subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), acted as the exclusive placement agent for the offering.

This announcement is neither an offer to sell nor a solicitation of an offer to buy any securities of the Company. The securities offered an
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight
2. Spherix Announces Annual Shareholders Meeting Date
3. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
4. Spherix Regains Compliance With NASDAQ Listing Rule
5. Spherix Announces First Quarter Financial Results
6. Spherix Announces Reverse Stock Split Effective May 6, 2011
7. Spherix to Effect Reverse Stock Split
8. Spherix Announces 2010 Financial Results
9. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
10. Spherix to Present at the 13th Annual BIO CEO & Investor Conference
11. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... PA (PRWEB) September 30, 2014 ... ( IACRN), a non-profit organization based in ... Research Excellence and Safety (ACRES), a Massachusetts ... a strategic alliance agreement, setting the stage for ... to enhance clinical research quality and safety through ...
(Date:9/29/2014)... , Sept. 29, 2014  Ten of ... fields of cartilage repair, regeneration, allograft reconstruction and ... around the world gathered to discuss the future ... Institute of Regenerative Medicine symposium, Cartilage Regeneration: ... Topics included Orthopedic Biosurgery, Minced Juvenile Allograft, and ...
(Date:9/29/2014)... lithium batteries are efficient but involve a range ... alfalfa (lucerne seed) and pine resin and a ... up with a highly interesting alternative. Their study ... ChemSusChem . , ,We think our discovery ... solutions for the batteries of the future, says ...
(Date:9/29/2014)... Diego, CA (PRWEB) September 29, 2014 ... Chen at Yale University the 2014 iCELLigence Research ... resistance studies. ACEA’s iCELLigence instrument is an impedance ... a Ph.D. candidate in Department of Biomedical Engineering ... Research Fellowship. Chen’s research projects in Professor ...
Breaking Biology Technology:IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3World Renowned Experts Discuss Future Of Cartilage Regeneration 2World Renowned Experts Discuss Future Of Cartilage Regeneration 3Smart, eco-friendly new battery to solve problems 2ACEA Biosciences, Inc. Awards Yale University Researcher the iCELLigence Research Grant 2
... Medical,Innovations, Inc. (Amex: IMA ), a ... management services, announced that it received today ... directed at,Inverness, Binax subsidiary, awards Binax,s distributor ... interest and arbitration,related expenses. While Inverness is ...
... 25 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) ... ended June 30, 2008, of $108.3 million, as compared ... This represents an,increase of 206% over the first quarter ... the first quarter of Fiscal 2009 as compared to ...
... Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... call on Friday, August 8th at 8:30,AM ET, ... 2008. Insmed intends,to issue its quarterly financial results ... To participate in the live conference call, ...
Cached Biology Technology:Arbitration Panel Issues Ruling in Distribution Dispute 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Insmed to Host Second Quarter 2008 Conference Call 2
(Date:9/30/2014)... can live in almost any aquatic environment on Earth, ... many species are pushed to the limit. The amount ... prove critical for how different species cope in the ... University of Gothenburg, published in the scientific journal ... change continues apace thanks to increasing levels of greenhouse ...
(Date:9/30/2014)... you want your doctor to know what goes wrong with ... good idea to know what "normal" actually is. That,s where ... of the FASEB Journal comes in. ... transcriptomea key set of molecules that can help scientists "see" ... time. What,s more, they found never-before-detected gene activity and that ...
(Date:9/30/2014)... People who suffer from asthma may think there,s not ... besides properly taking medications and avoiding allergic triggers. ... Annals of Allergy, Asthma and Immunology , the scientific ... Immunology (ACAAI), asthma sufferers can learn lessons about managing ... in the Annals article improved her asthma once she ...
Breaking Biology News(10 mins):Shape up quickly -- applies to fish, too! 2Scientists identify which genes are active in muscles of men and women 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... (March 26, 2009) The Howard Hughes Medical Institute ... Career Scientist appointment, a six-year funded position that allows ... am thrilled to receive the HHMI Early Career Scientist ... of supporting innovative and creative science, and I am ...
... team from the National Institute of Standards and Technology ... how to detect and monitor the tiny amount of ... atomic force microscope probe, and in so doing has ... instruments measurements under ambient conditions. Their recently reported work* ...
... researchers from the U.S., Europe, Taiwan and Japan and led ... agent that is about 200 times more active in killing ... The study appears this week in the ... agent belongs to a class of drugs called bisphosphonates. These ...
Cached Biology News:Whitehead member Peter Reddien named HHMI Early Career Scientist 2Making a point: Picoscale stability in a room-temperature AFM 2New drug agent knocks out multiple enzymes in cancer pathway 2
... samples may be carried out using this ... operator attention. System control and data processing ... 4900. The elegant, powerful and very easy ... Windows 98 and 2000., The supplied automatic sample ...
... in Minimum Essential Medium (Eagle) with 2 mM ... growth. In order to keep the antigens ... acetone-methanol. The cells are arrayed on a ... wells surface specifically treated to enhance cellular attachment ...
Mouse polyclonal antibody to REXO4 - XPMC2 prevents mitotic catastrophe 2 homolog (Xenopus laevis)...
... CellBIND surface is produced by a patented ... surface giving more consistent, even cell attachment, ... cell attachment and growth uunder difficult conditions, ... CellBIND may provide a more ecominic alternative ...
Biology Products: